Australia Stock Market Research Platform ยท Modern, Trustworthy & Data-Driven.
ASX COVERAGE SNAPSHOT
360 $21.06 +0.05%
BHP $42.85 +1.24%
BPT $0.96 +0.05%
CBA $132.64 +0.86%
AUSTRALIA EQUITY RESEARCH DESK

ASX company research

Find a company, compare the research collections, and open the report that answers your next question.

3 research reports found
Latest Published First
Prescient Therapeutics ASX:PTX research report
Penny Stocks Report โ—‹ OPEN
P
PTX Prescient Therapeutics ASX:PTX Healthcare · Small Cap
Buy

Prescient Therapeutics

Historical analysis of Prescient Therapeutics (ASX:PTX), adapted for Sharesrise. Figures are dated and may no longer apply.

06 Aug 2026 · 5 min read Read Report โ†’
Prescient Therapeutics ASX:PTX research report
Penny Stocks Report โ—‹ OPEN
P
PTX Prescient Therapeutics ASX:PTX Healthcare · Small Cap
Buy

Prescient Therapeutics

Historical analysis of Prescient Therapeutics (ASX:PTX), adapted for Sharesrise. Figures are dated and may no longer apply.

06 Aug 2026 · 5 min read Read Report โ†’
Mach7 Technologies Limited ASX-M7T research report
Penny Stocks Report โ—‹ OPEN
M
M7T Mach7 Technologies Limited ASX-M7T Healthcare · Small Cap
Buy

Mach7 Technologies Limited

Historical analysis of Mach7 Technologies Limited (ASX:M7T), adapted for Sharesrise. Figures are dated and may no longer apply.

23 Jul 2026 · 5 min read Read Report โ†’

Disclaimer: Sharesrise provides stock market research, investment insights, and general information relating to Australian Securities Exchange (ASX) listed companies. Sharesrise | ABN: 52 435 298 361. All information published on this website is intended for general informational and educational purposes only and does not constitute personalised financial advice. Sharesrise does not consider your individual financial circumstances, investment objectives, or financial needs. Investing in financial markets involves risks, and past performance is not a reliable indicator of future returns. Sharesrise does not guarantee investment performance, profitability, or returns. Investors are encouraged to conduct their own research and seek advice from a suitably licensed financial adviser before making investment decisions.